Abbott Laboratories (NYSE: NYSE:ABT) has demonstrated resilience and growth potential in the healthcare sector, maintaining a strong financial profile despite facing various challenges. According to ...

Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device ...

Morgan Stanley analyst Patrick Wood maintained a Hold rating on Abbott Laboratories (ABT – Research Report) yesterday and set a price target of ...

Abbott's Q4 sales grow 7.2%, missing estimates, but analysts remain upbeat with strong 2025 projections driven by Diabetes ...

Analyst Lee Hambright of Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), boosting the price target to ...

From medical devices to OTC drugs, preemption to expert preclusion, New York state and federal courts issued decisions in ...

Abbott also is a buy for its dividend strength. As a Dividend King it's raised its dividend for more than 50 consecutive ...

A few weeks ago, an allergist prescribed a two-week course of an oral steroid to clear up my sinus inflammation. Before I ...

Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics has now set its financial goalposts, aiming to raise $114.4m from the initial public ...

AI, the leading private enterprise AI platform, today unveiled Companion, a breakthrough AI assistant customized to the needs of any enterprise work stream. By securely combining LLMs with proprietary ...

Section 31,” a new movie streaming Friday on Paramount+, is pretty much the “Star Trek” version of “Suicide Squad” as a group ...

The machines, which cost six figures and are used during heart surgery, will now have to be repaired by the company directly.